BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25176022)

  • 21. Impaired Left Ventricular Reserve in Childhood Cancer Survivors Treated With Anthracycline Therapy.
    Kaneko S; Tham EB; Haykowsky MJ; Spavor M; Khoo NS; Mackie AS; Smallhorn JF; Thompson RB; Nelson MD
    Pediatr Blood Cancer; 2016 Jun; 63(6):1086-90. PubMed ID: 26844944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the left atrium of childhood cancer survivors.
    Loar RW; Colquitt JL; Rainusso NC; Gramatges MM; Liu AM; Noel CV; Tunuguntla HP; Lilje C; Pignatelli RH
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):155-162. PubMed ID: 32803485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
    Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
    Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
    Ylänen K; Poutanen T; Savikurki-Heikkilä P; Rinta-Kiikka I; Eerola A; Vettenranta K
    J Am Coll Cardiol; 2013 Apr; 61(14):1539-47. PubMed ID: 23500246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac function in Wilms' tumor survivors.
    Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I
    J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.
    Ganame J; Claus P; Uyttebroeck A; Renard M; D'hooge J; Bijnens B; Sutherland GR; Eyskens B; Mertens L
    J Am Soc Echocardiogr; 2007 Dec; 20(12):1351-8. PubMed ID: 17604960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
    Rathe M; Carlsen NL; Oxhøj H
    Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.
    Amedro P; Vincenti M; Abassi H; Lanot N; De La Villeon G; Guillaumont S; Gamon L; Mura T; Lopez-Perrin K; Haouy S; Sirvent A; Cazorla O; Vergely L; Lacampagne A; Avesani M; Sirvent N; Saumet L
    Int J Cardiol; 2022 May; 354():75-83. PubMed ID: 35167907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
    Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
    J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
    Lanzarini L; Bossi G; Laudisa ML; Klersy C; Aricò M
    Am Heart J; 2000 Aug; 140(2):315-23. PubMed ID: 10925349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivors of Pediatric Hematopoietic Stem Cell Transplantation Exhibit Progressive Diastolic Dysfunction Over Years of Follow-Up.
    Harrison DJ; Daly KP; Gauvreau K; Epstein SF; Walsh ML; Colan S; Duncan C; Lehmann L; Chen MH
    Transplant Cell Ther; 2023 Dec; 29(12):774.e1-774.e8. PubMed ID: 37666455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.
    Armenian SH; Hudson MM; Chen MH; Colan SD; Lindenfeld L; Mills G; Siyahian A; Gelehrter S; Dang H; Hein W; Green DM; Robison LL; Wong FL; Douglas PS; Bhatia S
    BMC Cardiovasc Disord; 2016 Oct; 16(1):187. PubMed ID: 27716152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.
    Armenian SH; Gelehrter SK; Vase T; Venkatramani R; Landier W; Wilson KD; Herrera C; Reichman L; Menteer JD; Mascarenhas L; Freyer DR; Venkataraman K; Bhatia S
    Clin Cancer Res; 2014 Dec; 20(24):6314-23. PubMed ID: 24947931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.
    Koelwyn GJ; Lewis NC; Ellard SL; Jones LW; Gelinas JC; Rolf JD; Melzer B; Thomas SM; Douglas PS; Khouri MG; Eves ND
    Oncologist; 2016 Feb; 21(2):141-9. PubMed ID: 26764251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue and flow myocardial performance index measurements taken during dobutamine stress echocardiography for early diagnosis of late anthracycline cardiotoxicity.
    Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
    Pediatr Cardiol; 2010 Jan; 31(1):96-105. PubMed ID: 19937012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.
    Kapusta L; Groot-Loonen J; Thijssen JM; DeGraaf R; Daniëls O
    Med Pediatr Oncol; 2003 Nov; 41(5):426-35. PubMed ID: 14515381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of long-term cardiac side effects of anthracycline chemotherapy by conventional and non-conventional echocardiographic methods in childhood cancer survivors.
    Yoldaş T; Yeşil Ş; Karademir S; Şahin G; Arman Örün U; Doğan V; Özgür S
    Cardiol Young; 2019 Jul; 29(7):904-909. PubMed ID: 31218970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
    Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiographic Assessment of Cardiac Function in Pediatric Survivors of Anthracycline-Treated Childhood Cancer.
    Slieker MG; Fackoury C; Slorach C; Hui W; Friedberg MK; Fan CS; Manlhiot C; Dillenburg R; Kantor P; Mital S; Liu P; Nathan PC; Mertens L
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e008869. PubMed ID: 31826678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.